ARCHIVES

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

ACS Funds $54 Million in Grants

June 28, 2002

Funding Opportunities.

July 19, 2002

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990